Advertisement

Topics

Alzheimer’s Disease Toxicity Halted by Synthetic Peptides

10:00 EDT 16 Apr 2019 | Genetic Engineering News

Alzheimer’s disease (AD) is characterized by the formation of large, insoluble deposits, or plaques, of amyloid-β peptide (Aβ) in the brain. These plaques are generated by the aggregation of smaller, soluble clumps made up of perhaps a dozen or so Aβ monomers. Recent research indicates that it is these smaller Aβ aggregates, or oligomers, and […]

The post Alzheimer’s Disease Toxicity Halted by Synthetic Peptides appeared first on GEN - Genetic Engineering and Biotechnology News.

Original Article: Alzheimer’s Disease Toxicity Halted by Synthetic Peptides

NEXT ARTICLE

More From BioPortfolio on "Alzheimer’s Disease Toxicity Halted by Synthetic Peptides"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...

Alzheimer's Disease
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...